Skip to main content
. 2023 Jul 4;3(5):724–735. doi: 10.1016/j.jacasi.2023.05.010

Figure 4.

Figure 4

Representativeness of APAC Trial Enrollment by Burden of Disease

Proportion of enrolled APAC participants (red) by therapeutic area. Proportion of global burden of disease arising from APAC region (blue) by therapeutic area using Global Health Data Exchange registry and other published sources. Participant-to-prevalence ratio (PPR) determined by dividing APAC enrollment by APAC prevalence. APAC = Asia-Pacific; CAD = coronary artery disease; CeVD = cerebral artery disease; DVT = deep venous thrombosis; HF = heart failure; PE = pulmonary embolism.